{"doi":"10.2147/imcrj.s524362","title":"Valsalva Retinopathy in Pregnancy: A Case Report and Review of the Literature","abstract":"The current case report and literature review evaluate the management and optimal mode of delivery for Valsalva retinopathy in pregnancy. A 30-year-old primigravid female was discussed presenting with Valsalva retinopathy in the left eye at 35 weeks of gestation after dry heaving with a visual acuity of 20/200. Four weeks after cesarean-section, she had worse central vision and improving residual hemorrhage. A literature review of 25 Valsalva retinopathy cases showed all patients treated with laser posterior hyaloidotomy or pars plana vitrectomy achieved complete resolution (median of 1.5 weeks, p = 0.08), compared to 67% of untreated eyes (median of 5 months, p = 0.08). Average final visual acuity was 20/30 for the treated and untreated cohorts. Intervention may result in faster recovery time but with similar final visual acuity. Four (15%) cases of Valsalva retinopathy were incited by vaginal delivery. However, neither vaginal delivery nor cesarean section resulted in recurrence/worsening of premacular hemorrhage. These findings may help guide treatment of challenging Valsalva retinopathy cases in pregnancy.","journal":"International Medical Case Reports Journal","year":2025,"id":569347,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":0,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.949,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2025-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1474267,"name":"Faiza Sarwar","orcid":"0000-0002-8539-7881","position":1,"is_corresponding":false},{"id":706118,"name":"Noy Ashkenazy","orcid":"0000-0001-7497-4439","position":2,"is_corresponding":false},{"id":1474266,"name":"Brenda Zhou","orcid":"0000-0002-9532-0570","position":0,"is_corresponding":true}],"reference_count":31,"raw_metadata":null,"created_at":"2026-07-19T02:56:59.652443Z","pmid":"40621446","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}